Format

Send to

Choose Destination
Skin Pharmacol Physiol. 2012;25(6):305-12. doi: 10.1159/000341809. Epub 2012 Aug 31.

Efficacy and patient-reported outcomes of a new mometasone cream treating atopic eczema.

Author information

1
Department of Dermatology and Allergology, Klinikum Innenstadt Munich, Munich, Germany. Thomas.Ruzicka@med.uni-muenchen.de

Abstract

This double-blind controlled phase II study was conducted to compare a newly developed formulation of mometasone furoate with a water content of 33% (Monovo® Cream) and with a smooth consistency versus the commercially available fatty cream of mometasone furoate (Ecural® Fettcreme) in terms of efficacy, cosmetic properties, and patients' acceptance. In 20 patients with mild to moderate atopic eczema, the preparations were tested intraindividually in a randomized mode and in two comparable lesion areas. Both preparations were equally effective and well tolerated. Due to improved cosmetic properties, the new formulation was preferred by the patients when asked for preferential use. Quality of life could be improved by treating with both preparations.

TRIAL REGISTRATION:

ClinicalTrials.gov NCT01119313.

PMID:
22948032
DOI:
10.1159/000341809
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center